Inhalol is used as an auxiliary, in the form of inhalation inhalation, to relieve upper respiratory tract ailments such as runny nose and difficulties in expectorating thick secretions.

The product is intended for traditional use in the above-mentioned indications and its effectiveness is based solely on long-term use and experience.

Active substances: Menthae piperitae folium, Pini sylvestris aetheroleum, Terebinthini aetheroleum ab pinum pinastrum, Thymi aetheroleum

Composition of Inhalol

• Pini sylvestris aetheroleum 10.0 g
• Thymi aetheroleum 10.0 g
• Menthae piperithae aetheroleum 20.0 g
• Terbinthinae aetheroleum and Pino pinastro 60.0 g

Dosage

For inhalation purposes for children over 7 years of age and adults: add a few drops of the preparation to a vessel with hot water and inhale the resulting vapors. Inhalation can be carried out by adding a few drops to a hot bath or using special inhalation devices.

Contraindications

The preparation should not be used in people who are allergic to any of the ingredients, as well as in patients with asthma, whooping cough and in children under 7 years of age.

Contents
Color glass bottle with a polyethylene dispenser and a polyethylene cap, the amount of the preparation in the package 10g. The bottle is fitted with a stopper for dispensing in the form of drops.
Storage method
15°C-25°C
Manufacturer
PROFARM

Warnings

Avoid contact of the drug with the mucous membranes of the eyes, mouth and nose, and wash it off with water if necessary. It is not recommended to apply directly to the skin around the neck, face and nose due to the possibility of bronchospasm.

Pregnancy and lactation
Due to the lack of data on safety, it is not recommended to use the preparation during pregnancy and breastfeeding.

Driving vehicles
Does not affect.
Overdosage
There is no data on drug overdose. If you notice any alarming symptoms, stop using the drug and consult a doctor

Interactions with other drugs
So far it has not been found.

Side effects

Allergic skin reactions, irritation of the mucous membranes, increased bronchospasm may occur. In the event of the above symptoms, the preparation should be discontinued.